LUMAKRAS is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Sotorasib.
Product ID | 55513-488_3b378de2-ac6e-4f2b-9d8a-9ea72f0f9374 |
NDC | 55513-488 |
Product Type | Human Prescription Drug |
Proprietary Name | LUMAKRAS |
Generic Name | Sotorasib |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2021-05-28 |
Marketing Category | NDA / |
Application Number | NDA214665 |
Labeler Name | Amgen Inc |
Substance Name | SOTORASIB |
Active Ingredient Strength | 120 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-05-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LUMAKRAS 97248835 not registered Live/Pending |
Amgen Inc. 2022-02-01 |
LUMAKRAS 90532537 not registered Live/Pending |
Amgen Inc, 2021-02-17 |
LUMAKRAS 90044720 not registered Live/Pending |
Amgen Inc. 2020-07-09 |